Treanda for Chronic Lymphocytic Leukemia (First Line) (Treanda) (Mise à jour: 02 sep 2016)
As per pCODR Procedures B5.4, the pERC deliberations for Bendamustine (Treanda) First Line treatment of patients with CLL were deferred to the January 17, 2013 pERC meeting date, once the submitter...
Gamme de produits:
Examen en vue du remboursement
État du projet:
Terminé
Contains:
Brand Name
Fabricant
Submission Type
Indication
Brand Name:
Treanda
Fabricant:
Lundbeck Canada Inc.
Submission Type:
Initial